Year: 1992 Source: Psychopharmacology Bulletin, v.28, no.1, (1992), p.3-9 SIEC No: 19920754

Serotonin basic neuroscience discoveries are evolving at a very fast pace & are leading to innovations in clinical psychiatry & in drug development. Serotonin 1A agonists are targetting not only depression & anxiety, but also mixed anxiety depression. These & other agents selective for additional receptors are being tested in impulse control disorders; eating disorders; addictive disorders; & aggressive, violent, self-destructive & suicidal behaviours. (18 refs.)